Bardia Moayedi is a corporate and securities partner, chair of the firm’s Technology Industry Group and co-chair of the firm's Life Sciences Industry Group. He primarily advises emerging growth and public companies throughout their life cycles as well as venture capital and private equity firms, particularly in the life sciences, high-technology, financial technology, food and beverage, and clean-technology industries.
Bardia has significant experience representing companies and financial firms in a broad range of general corporate governance and transactional matters, including venture capital financings, mergers and acquisitions, debt offerings, spin-offs/divestitures, joint ventures, IPOs, follow-on offerings, and tender offers. He is a trusted advisor, often serving as the go-to outside counsel or lead counsel to his clients.
In addition to his normal areas of practice, Bardia is a member of the firm’s Coronavirus (COVID-19) Response Team, an interdisciplinary team of lawyers, formed quickly after recognizing the complex legal issues that businesses would confront as a result of the coronavirus. This group has issued legal alerts and newsletters on the topic and has hosted multiple webinars to address a range of concerns. The group remains committed to monitoring the issues and bringing as much clarity and guidance to clients as possible. More information is available in the COVID-19 Resource Center.
Prior to attending law school, Bardia worked at a prominent investment bank, where he focused on hedge funds and private equity funds. As an undergraduate, he played ice and roller hockey at UCLA.
vCard